JP2016534062A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016534062A5 JP2016534062A5 JP2016525504A JP2016525504A JP2016534062A5 JP 2016534062 A5 JP2016534062 A5 JP 2016534062A5 JP 2016525504 A JP2016525504 A JP 2016525504A JP 2016525504 A JP2016525504 A JP 2016525504A JP 2016534062 A5 JP2016534062 A5 JP 2016534062A5
- Authority
- JP
- Japan
- Prior art keywords
- immune complex
- lyophilized composition
- spdb
- complex preparation
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 3
- 238000009472 formulation Methods 0.000 claims description 2
- 229940127121 immunoconjugate Drugs 0.000 claims description 2
- 230000008929 regeneration Effects 0.000 claims description 2
- 238000011069 regeneration method Methods 0.000 claims description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims 4
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 claims 4
- 238000002360 preparation method Methods 0.000 claims 4
- 239000004471 Glycine Substances 0.000 claims 2
- 229930006000 Sucrose Natural products 0.000 claims 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims 2
- 229960002885 histidine Drugs 0.000 claims 2
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 claims 2
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 claims 2
- 229920000053 polysorbate 80 Polymers 0.000 claims 2
- 229940068968 polysorbate 80 Drugs 0.000 claims 2
- 239000000243 solution Substances 0.000 claims 2
- 239000005720 sucrose Substances 0.000 claims 2
- 239000012062 aqueous buffer Substances 0.000 claims 1
- 238000004108 freeze drying Methods 0.000 claims 1
- 239000007788 liquid Substances 0.000 claims 1
- 230000001172 regenerating effect Effects 0.000 claims 1
- 230000001225 therapeutic effect Effects 0.000 claims 1
- 230000007774 longterm Effects 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP13190276 | 2013-10-25 | ||
| EP13190276.9 | 2013-10-25 | ||
| PCT/EP2014/072558 WO2015059147A1 (en) | 2013-10-25 | 2014-10-21 | A novel stable formulation |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016534062A JP2016534062A (ja) | 2016-11-04 |
| JP2016534062A5 true JP2016534062A5 (enExample) | 2018-12-27 |
| JP6813355B2 JP6813355B2 (ja) | 2021-01-13 |
Family
ID=49552164
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016525504A Expired - Fee Related JP6813355B2 (ja) | 2013-10-25 | 2014-10-21 | 新規な安定製剤 |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US20160250349A1 (enExample) |
| EP (1) | EP3060256B1 (enExample) |
| JP (1) | JP6813355B2 (enExample) |
| CY (1) | CY1121791T1 (enExample) |
| DK (1) | DK3060256T3 (enExample) |
| ES (1) | ES2735645T3 (enExample) |
| HR (1) | HRP20191053T1 (enExample) |
| HU (1) | HUE045020T2 (enExample) |
| LT (1) | LT3060256T (enExample) |
| PL (1) | PL3060256T3 (enExample) |
| PT (1) | PT3060256T (enExample) |
| RS (1) | RS58856B1 (enExample) |
| SI (1) | SI3060256T1 (enExample) |
| TR (1) | TR201909034T4 (enExample) |
| WO (1) | WO2015059147A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| UY32560A (es) | 2009-04-29 | 2010-11-30 | Bayer Schering Pharma Ag | Inmunoconjugados de antimesotelina y usos de los mismos |
| PL3570882T3 (pl) * | 2017-01-19 | 2022-02-07 | Bayer Pharma Aktiengesellschaft | Nowa stabilna formulacja dla przeciwciał fxia |
| BR112020003474A2 (pt) | 2017-08-23 | 2020-10-20 | Daiichi Sankyo Company, Limited | composição farmacêutica, e, método para produzir uma composição farmacêutica |
| WO2020234114A1 (en) | 2019-05-21 | 2020-11-26 | Bayer Aktiengesellschaft | A novel stable high concentration formulation for anetumab ravtansine |
| CN119630433A (zh) | 2022-05-23 | 2025-03-14 | 逻辑生物治疗公司 | 基因疗法组合物及其使用方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4703566B2 (ja) * | 2003-05-14 | 2011-06-15 | イムノゲン インコーポレーティッド | 薬剤複合体組成物 |
| JP2009503105A (ja) * | 2005-08-03 | 2009-01-29 | イミュノジェン・インコーポレーテッド | 免疫複合体製剤 |
| TW200806315A (en) * | 2006-04-26 | 2008-02-01 | Wyeth Corp | Novel formulations which stabilize and inhibit precipitation of immunogenic compositions |
| EP1854478A1 (en) * | 2006-05-12 | 2007-11-14 | Cytos Biotechnology AG | Nicotine-carrier vaccine formulation |
| UY32560A (es) * | 2009-04-29 | 2010-11-30 | Bayer Schering Pharma Ag | Inmunoconjugados de antimesotelina y usos de los mismos |
| AU2012244673A1 (en) * | 2011-04-21 | 2013-11-28 | Seattle Genetics, Inc. | Novel binder-drug conjugates (ADCs) and their use |
| CN103501825B (zh) * | 2011-05-02 | 2017-03-15 | 免疫医疗公司 | 用于小体积施用的同种异型选择的抗体的超滤浓缩 |
| BR112013030472A2 (pt) * | 2011-06-30 | 2019-09-24 | Genentech Inc | formulação farmacêutica, artigo de fabricação e método |
-
2014
- 2014-10-21 US US15/030,917 patent/US20160250349A1/en not_active Abandoned
- 2014-10-21 EP EP14786915.0A patent/EP3060256B1/en active Active
- 2014-10-21 PL PL14786915T patent/PL3060256T3/pl unknown
- 2014-10-21 HU HUE14786915A patent/HUE045020T2/hu unknown
- 2014-10-21 TR TR2019/09034T patent/TR201909034T4/tr unknown
- 2014-10-21 DK DK14786915.0T patent/DK3060256T3/da active
- 2014-10-21 RS RS20190692A patent/RS58856B1/sr unknown
- 2014-10-21 PT PT14786915T patent/PT3060256T/pt unknown
- 2014-10-21 WO PCT/EP2014/072558 patent/WO2015059147A1/en not_active Ceased
- 2014-10-21 HR HRP20191053TT patent/HRP20191053T1/hr unknown
- 2014-10-21 LT LTEP14786915.0T patent/LT3060256T/lt unknown
- 2014-10-21 SI SI201431230T patent/SI3060256T1/sl unknown
- 2014-10-21 ES ES14786915T patent/ES2735645T3/es active Active
- 2014-10-21 JP JP2016525504A patent/JP6813355B2/ja not_active Expired - Fee Related
-
2019
- 2019-02-12 US US16/274,015 patent/US20190240345A1/en not_active Abandoned
- 2019-07-03 CY CY20191100705T patent/CY1121791T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20200434T1 (hr) | Stabilne vodene formulacije adalimumaba | |
| MY193913A (en) | Stable Protein Solution Formulation Containing High Concentration of an Anti-Vegf Antibody | |
| EA201591524A1 (ru) | Производные 2-аминопиримидина для лечения вирусных инфекций | |
| EA033373B1 (ru) | Композиции на водной основе, предварительно наполненный шприц, их применения и способ доставки гипофукозилированного или нефукозилированного антитела против baffr млекопитающему | |
| EA201600305A1 (ru) | Вариант белка opc2 pcv2 и содержащие его вирусоподобные частицы | |
| EA201492021A1 (ru) | Антительный состав | |
| JP2016513069A5 (enExample) | ||
| JP2016534062A5 (enExample) | ||
| MX2017007178A (es) | Formulaciones liquidas estables de virus de vacuna. | |
| MX383706B (es) | Composiciones de cenicriviroc y métodos para elaborarlas y usarlas. | |
| EA201590667A1 (ru) | Ациламинопиримидиновые производные для лечения вирусных инфекций и других заболеваний | |
| CN108026053A8 (zh) | 作为mIDH1抑制剂的稠合的咪唑类化合物 | |
| EA201490610A1 (ru) | Соединения и способы усиления врожденных иммунных ответов | |
| JP2016510326A5 (enExample) | ||
| HK1251481A1 (zh) | 使用白介素-17(il-17)拮抗剂治疗放射学阴性中轴型脊柱关节炎的方法 | |
| MX2016015668A (es) | Procedimiento de disminucion de la inmunogenicidad de proteinas y peptidos. | |
| ECSP16084317A (es) | Formulaciones farmacéuticas, procesos para la preparación y métodos de uso | |
| EA201790223A1 (ru) | Водный препарат, содержащий парацетамол и ибупрофен | |
| PH12018000197A1 (en) | Hand, foot, and mouth vaccines and methods of manufacture and use thereof | |
| JP2015520196A5 (enExample) | ||
| UA110979C2 (uk) | Рідка фармацевтична композиція, яка включає нітизинон | |
| JP2016515623A5 (enExample) | ||
| EA201692111A1 (ru) | Фармацевтические композиции, содержащие данириксин, для лечения инфекционных заболеваний | |
| JO3565B1 (ar) | الأجسام المضادة لشبيه الأنجيوبوييتين– 4 وطرق استخدامها | |
| EA201500140A1 (ru) | Ослабленные вакцины от свиного гриппа и способы их получения и применения |